NexGen
Device
Zimmer Biomet Holdings, Inc.
Total Payments
$3.0M
Transactions
697
Doctors
182
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $10,945 | 11 | 6 |
| 2023 | $2.1M | 54 | 15 |
| 2022 | $101,115 | 43 | 24 |
| 2021 | $52,774 | 56 | 30 |
| 2020 | $99,893 | 44 | 16 |
| 2019 | $222,690 | 128 | 49 |
| 2018 | $191,479 | 175 | 44 |
| 2017 | $227,190 | 186 | 35 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Royalty or License | $2.2M | 35 | 71.4% |
| Unspecified | $543,363 | 183 | 17.9% |
| Consulting Fee | $189,738 | 128 | 6.2% |
| Travel and Lodging | $55,082 | 93 | 1.8% |
| Gift | $47,989 | 11 | 1.6% |
| Food and Beverage | $15,274 | 239 | 0.5% |
| Space rental or facility fees (teaching hospital only) | $12,860 | 3 | 0.4% |
| Education | $2,681 | 5 | 0.1% |
Payments by Type
General
$2.5M
514 transactions
Research
$543,363
183 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| NexGen TM Tibia Clinical Outcomes Study | Zimmer Biomet Holdings, Inc. | $326,204 | 5 |
| CW107745 ANCHOR CLINICAL RESEARCH PROJECT FAI Clohisy | Zimmer Biomet Holdings, Inc. | $67,247 | 0 |
| A Prospective, Randomized Study Comparing Cemented and Cementless Total Knee Replacement Results of a Modular Trabecular Metal Tibial Component Using the NexGen System at 5-Year Follow-up | Zimmer Biomet Holdings, Inc. | $43,600 | 1 |
| Zimmer Biomet Knee Clinical Surveys | Zimmer Biomet Holdings, Inc. | $41,544 | 0 |
| Knee PMS Survey Research | Zimmer Biomet Holdings, Inc. | $35,240 | 0 |
| NexGen LPS PAS | Zimmer Biomet Holdings, Inc. | $16,290 | 0 |
| Persona Partial Knee Clinical Outcomes Study | Zimmer Biomet Holdings, Inc. | $6,933 | 0 |
| Knee Registry | Zimmer Biomet Holdings, Inc. | $5,310 | 0 |
| Berkowitz, Richard, 04-500, TM Stem CSI 90-202 | Zimmer Biomet Holdings, Inc. | $700.00 | 0 |
| LPS-PAS Flex Mobile Bearing Knee | Zimmer Biomet Holdings, Inc. | $295.00 | 0 |
Top Doctors Receiving Payments for NexGen
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , M.B., CHB | Pediatric Surgery | Norfolk, VA | $958,309 | 5 |
| Unknown | — | Philadelphia, PA | $564,878 | 190 |
| , M.D | Pediatric Surgery | Norfolk, VA | $317,303 | 5 |
| , M.D | Pediatric Surgery | Norfolk, VA | $317,303 | 5 |
| , M.D | Thoracic Surgery (Cardiothoracic Vascular Surgery) | Phoenix, AZ | $284,766 | 5 |
| , MD | Orthopaedic Surgery | Nashville, TN | $97,348 | 5 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Midlothian, VA | $97,222 | 5 |
| , M.D | Orthopaedic Surgery | Rochester, MN | $97,138 | 5 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Beverly Hills, CA | $41,044 | 21 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Omaha, NE | $37,328 | 67 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Paradise Valley, AZ | $31,459 | 64 |
| , MD | Adult Reconstructive Orthopaedic Surgery | Arlington, VA | $26,160 | 2 |
| , MD | Orthopaedic Surgery | Weston, MA | $24,400 | 30 |
| , M.D | Orthopaedic Surgery | Scottsdale, AZ | $11,963 | 17 |
| , MD | Orthopaedic Surgery | Columbia, MO | $10,212 | 2 |
| , DO | Orthopaedic Surgery | Clarence, NY | $9,604 | 8 |
| , M.D | Orthopaedic Surgery | Rochester, MN | $9,259 | 2 |
| , MD | Orthopaedic Surgery | Bethlehem, PA | $9,256 | 10 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Philadelphia, PA | $9,133 | 2 |
| , MD | Sports Medicine | Temple Terrace, FL | $7,223 | 3 |
| , MD | Orthopaedic Surgery | Philadelphia, PA | $7,156 | 6 |
| Adam Kanter | Neurological Surgery | Pittsburgh, PA | $5,125 | 5 |
| , MD | Orthopaedic Surgery | Danville, PA | $5,087 | 2 |
| , M.D | Adult Reconstructive Orthopaedic Surgery | Winfield, IL | $4,840 | 3 |
| , M.D | Neurological Surgery | Pittsburgh, PA | $3,375 | 4 |
Ad
Manufacturing Companies
Product Information
- Type Device
- Total Payments $3.0M
- Total Doctors 182
- Transactions 697
About NexGen
NexGen is a device associated with $3.0M in payments to 182 healthcare providers, recorded across 697 transactions in the CMS Open Payments database. The primary manufacturer is Zimmer Biomet Holdings, Inc..
Payment data is available from 2017 to 2024. In 2024, $10,945 was paid across 11 transactions to 6 doctors.
The most common payment nature for NexGen is "Royalty or License" ($2.2M, 71.4% of total).
NexGen is associated with 10 research studies, including "NexGen TM Tibia Clinical Outcomes Study" ($326,204).